Emcure Pharmaceuticals receives upgrade in credit ratings from CRISIL
Emcure Pharmaceuticals has received upgrade in credit ratings from CRISIL for bank facilities of Rs 2,475.43 crore of the company as under:
Long term rating - CRISIL AA-/ Stable
Short term rating - CRISIL A1+
Top Jewellery Stocks in India
13 mins read . Nov 19, 2024
List of Stock Exchanges in India
16 mins read . Nov 19, 2024
Hindustan Unilever History
14 mins read . Nov 8, 2024
Explore our products
₹0 Brokerage *
Open Demat Account